Compare JUBILANT LIFE SCIENCES with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES PANACEA BIOTECH JUBILANT LIFE SCIENCES/
PANACEA BIOTECH
 
P/E (TTM) x 15.5 11.7 131.6% View Chart
P/BV x 1.8 2.8 63.9% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 JUBILANT LIFE SCIENCES   PANACEA BIOTECH
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-19
PANACEA BIOTECH
Mar-18
JUBILANT LIFE SCIENCES/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs898364 246.7%   
Low Rs618129 478.3%   
Sales per share (Unadj.) Rs572.096.8 591.0%  
Earnings per share (Unadj.) Rs36.2-12.4 -292.0%  
Cash flow per share (Unadj.) Rs59.5-2.9 -2,086.5%  
Dividends per share (Unadj.) Rs4.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs301.950.4 599.1%  
Shares outstanding (eoy) m159.2861.25 260.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.32.5 52.0%   
Avg P/E ratio x20.9-19.9 -105.3%  
P/CF ratio (eoy) x12.7-86.4 -14.7%  
Price / Book Value ratio x2.54.9 51.3%  
Dividend payout %12.40-   
Avg Mkt Cap Rs m120,69415,101 799.2%   
No. of employees `0002.42.5 96.8%   
Total wages/salary Rs m19,2601,516 1,270.5%   
Avg. sales/employee Rs Th38,120.62,401.9 1,587.1%   
Avg. wages/employee Rs Th8,058.4614.2 1,312.0%   
Avg. net profit/employee Rs Th2,414.3-307.9 -784.0%   
INCOME DATA
Net Sales Rs m91,1085,928 1,536.9%  
Other income Rs m35782 434.3%   
Total revenues Rs m91,4666,010 1,521.8%   
Gross profit Rs m17,390845 2,057.3%  
Depreciation Rs m3,709585 633.7%   
Interest Rs m2,1981,006 218.5%   
Profit before tax Rs m11,840-664 -1,784.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m02 0.0%   
Extraordinary Inc (Exp) Rs m-2,8020-   
Tax Rs m3,26899 3,314.4%   
Profit after tax Rs m5,770-760 -759.2%  
Gross profit margin %19.114.3 133.9%  
Effective tax rate %27.6-14.9 -185.7%   
Net profit margin %6.3-12.8 -49.4%  
BALANCE SHEET DATA
Current assets Rs m45,8485,603 818.2%   
Current liabilities Rs m20,8976,910 302.4%   
Net working cap to sales %27.4-22.0 -124.2%  
Current ratio x2.20.8 270.6%  
Inventory Days Days57206 27.6%  
Debtors Days Days5184 60.8%  
Net fixed assets Rs m65,4989,941 658.9%   
Share capital Rs m15961 259.9%   
"Free" reserves Rs m47,9303,026 1,584.1%   
Net worth Rs m48,0893,087 1,557.8%   
Long term debt Rs m42,4295,707 743.4%   
Total assets Rs m114,68516,076 713.4%  
Interest coverage x6.40.3 1,876.6%   
Debt to equity ratio x0.91.8 47.7%  
Sales to assets ratio x0.80.4 215.4%   
Return on assets %6.91.5 454.4%  
Return on equity %12.0-24.6 -48.7%  
Return on capital %12.43.9 317.0%  
Exports to sales %024.0 0.0%   
Imports to sales %017.5 0.0%   
Exports (fob) Rs mNA1,424 0.0%   
Imports (cif) Rs mNA1,040 0.0%   
Fx inflow Rs m12,4221,600 776.4%   
Fx outflow Rs m17,2271,131 1,522.6%   
Net fx Rs m-4,805469 -1,025.4%   
CASH FLOW
From Operations Rs m11,2151,180 950.3%  
From Investments Rs m-10,118553 -1,830.1%  
From Financial Activity Rs m6,574-1,644 -400.0%  
Net Cashflow Rs m7,61290 8,486.3%  

Share Holding

Indian Promoters % 45.6 74.5 61.2%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 0.6 1,450.0%  
FIIs % 21.2 1.3 1,630.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 23.6 89.4%  
Shareholders   23,815 10,259 232.1%  
Pledged promoter(s) holding % 15.9 35.1 45.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   SHASUN PHARMA  WYETH LTD  ABBOTT INDIA  ALEMBIC LTD  DR. REDDYS LAB  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 334 Points Lower; IT and Telecom Stocks Witness Huge Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 334 points (down 0.9%).

Related Views on News

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Oct 22, 2019 03:37 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - PROCTER & GAMBLE HEALTH COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS